Teladoc Health (NYSE:TDOC) Given New $15.00 Price Target at TD Cowen

Teladoc Health (NYSE:TDOC) had its price objective cut by TD Cowen from $16.00 to $15.00 in a report released on Friday morning, Benzinga reports. They currently have a hold rating on the health services provider’s stock.

A number of other research analysts have also recently commented on the company. Leerink Partnrs restated a market perform rating on shares of Teladoc Health in a research note on Monday, February 26th. DA Davidson cut their price objective on shares of Teladoc Health from $22.00 to $18.00 and set a neutral rating on the stock in a report on Wednesday, February 21st. SVB Leerink started coverage on shares of Teladoc Health in a report on Monday, February 26th. They issued a market perform rating and a $17.00 price objective on the stock. Needham & Company LLC restated a hold rating on shares of Teladoc Health in a research note on Friday. Finally, Stifel Nicolaus dropped their price objective on shares of Teladoc Health from $21.00 to $16.00 and set a hold rating on the stock in a research note on Friday. Eleven investment analysts have rated the stock with a hold rating and six have issued a buy rating to the company. According to data from MarketBeat, Teladoc Health currently has an average rating of Hold and a consensus price target of $19.67.

Teladoc Health Stock Performance

NYSE TDOC opened at $13.01 on Friday. Teladoc Health has a twelve month low of $12.65 and a twelve month high of $30.41. The company has a quick ratio of 3.47, a current ratio of 3.54 and a debt-to-equity ratio of 0.66. The stock has a 50-day moving average of $15.01 and a 200 day moving average of $17.77.

Teladoc Health (NYSE:TDOC) last released its quarterly earnings results on Thursday, April 25th. The health services provider reported ($0.49) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.47) by ($0.02). The business had revenue of $646.13 million during the quarter, compared to analyst estimates of $637.31 million. Teladoc Health had a negative return on equity of 10.11% and a negative net margin of 8.90%. The business’s revenue for the quarter was up 2.7% compared to the same quarter last year. During the same period in the previous year, the company posted ($0.37) EPS. As a group, equities research analysts expect that Teladoc Health will post -1.07 earnings per share for the current fiscal year.

Insider Buying and Selling

In other Teladoc Health news, EVP Andrew Turitz sold 6,190 shares of the stock in a transaction on Monday, March 4th. The shares were sold at an average price of $14.52, for a total value of $89,878.80. Following the completion of the sale, the executive vice president now owns 39,429 shares in the company, valued at $572,509.08. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. In other news, EVP Andrew Turitz sold 6,190 shares of the stock in a transaction dated Monday, March 4th. The shares were sold at an average price of $14.52, for a total value of $89,878.80. Following the transaction, the executive vice president now directly owns 39,429 shares of the company’s stock, valued at $572,509.08. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Daniel Trencher sold 6,780 shares of the stock in a transaction dated Monday, March 4th. The shares were sold at an average price of $14.52, for a total transaction of $98,445.60. Following the completion of the transaction, the insider now directly owns 28,192 shares in the company, valued at $409,347.84. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 135,441 shares of company stock worth $2,038,251. 1.63% of the stock is owned by insiders.

Institutional Investors Weigh In On Teladoc Health

A number of large investors have recently bought and sold shares of TDOC. Lecap Asset Management Ltd. acquired a new stake in shares of Teladoc Health in the 4th quarter valued at approximately $1,530,000. Sowell Financial Services LLC boosted its stake in shares of Teladoc Health by 40.8% in the 4th quarter. Sowell Financial Services LLC now owns 18,907 shares of the health services provider’s stock valued at $407,000 after purchasing an additional 5,475 shares in the last quarter. Deutsche Bank AG boosted its stake in shares of Teladoc Health by 12.4% in the 3rd quarter. Deutsche Bank AG now owns 301,147 shares of the health services provider’s stock valued at $5,598,000 after purchasing an additional 33,287 shares in the last quarter. Sherbrooke Park Advisers LLC acquired a new stake in shares of Teladoc Health in the 3rd quarter valued at approximately $680,000. Finally, QRG Capital Management Inc. acquired a new stake in shares of Teladoc Health in the 3rd quarter valued at approximately $392,000. 76.82% of the stock is currently owned by institutional investors and hedge funds.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.